<DOC>
	<DOC>NCT00770458</DOC>
	<brief_summary>Validate that circulating cell free fetal nucleic acid can be used to identify a direct marker for fetal aneuploidy, particularly fetal Down Syndrome (DS), that is better than surrogate markers.</brief_summary>
	<brief_title>Non-Invasive Screening for Fetal Aneuploidy: A New Maternal Plasma Marker</brief_title>
	<detailed_description />
	<mesh_term>Syndrome</mesh_term>
	<mesh_term>Down Syndrome</mesh_term>
	<mesh_term>Aneuploidy</mesh_term>
	<mesh_term>Trisomy</mesh_term>
	<mesh_term>Turner Syndrome</mesh_term>
	<mesh_term>Gonadal Dysgenesis</mesh_term>
	<mesh_term>Primary Ovarian Insufficiency</mesh_term>
	<criteria>Subject is female Subject is pregnant Subject is high risk aneuploid patient undergoing genetic counseling, unltrasound screening, amniocentesis and/or CVS procedure Subject is willing to provide blood specimen Subject is not pregnant Subject is not willing to provide blood specimen Subject is not haveing aneuploid screening</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2010</verification_date>
	<keyword>Down Syndrome</keyword>
</DOC>